local_hospital

Praxis Dr. Wolfgang Friedrich

Address
Bleichenbrücke 10, 20354 Hamburg, Germany

Praxis Dr. Wolfgang Friedrich - Allergy & Immunotherapy Research

Praxis Dr. Wolfgang Friedrich is a specialized clinical research center focused on allergic conditions and innovative immunotherapy approaches. The center conducts advanced clinical trials evaluating novel treatment modalities for patients with respiratory allergies, with particular emphasis on developing personalized therapeutic solutions for allergic rhinitis and rhinoconjunctivitis.

  • Sublingual immunotherapy (SLIT) for seasonal allergies
  • Birch pollen allergy treatment and dose optimization studies
  • Allergic rhinitis and rhinoconjunctivitis management

The center specializes in Phase II-III clinical trials that evaluate both efficacy and safety of immunotherapy products, utilizing comprehensive outcome measures such as the Combined Symptom and Medication Score (CSMS). With expertise in treating moderate-to-severe allergic rhinitis following ARIA guidelines, the practice contributes to advancing allergen-specific immunotherapy options that improve quality of life for patients suffering from seasonal pollen allergies.

Site Overview

assignment
2
connected trials
corporate_fare
1
sponsor
science
26
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 1 therapeutic areas and 15 of 26 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
1
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
2
Outperforms 47% of sites
public
Therapeutic diversity
1areas
Outperforms 2% of sites
groups
Sponsor diversity
1sponsors
Outperforms 2% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Praxis Dr. Wolfgang Friedrich

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety Evaluation of Phleum Pratense Pollen Extract Sublingual Immunotherapy in Patients with Moderate-to-Severe Grass Pollen-Induced Allergic RhinitisROXALL Medizin GmbHPhase IVNot RecruitingNov 2023Nov 2024

IMP list

lock Showing 1 of 26 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Alternaria Alternata (402)2Unknown2023-08-222023-11-10

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.